A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

When it comes to nondrug or natural remedies for migraine, sometimes it's hard to sort the snake oil from the science.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Electrical Nerve Stimulation Eases Long COVID Pain and ... peptide hormone oxytocin that drives childbirth ... Neuropathic Pain Drugs Found to Increase Risk of Hip Fracture in Older Adults Nov.

Discover effective knee pain solutions. Explore when knee replacement is necessary and how regenerative therapies offer ...

They are also useful for conditions like anxiety disorders and long-term pain. So, SNRIs may be of help to those with chronic pain (particularly nerve pain) as well as depression. Drugs in this class ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...